IP Library Granted Patent US 10,695,228
Granted Patent B2
US 10,695,228 · App. 15/591,180 · Granted Jun 30, 2020

Flexible means for determining the extent of debridement required to remove non-viable tissue

Inventors: Justin Alexander Long (Bournemouth, GB); Sandra Garcia-Osborne (San Antonio, TX); Timothy Mark Robinson (Shillingstone, GB); Christopher Brian Locke (Bournemouth, GB); Daniel W. Dekruif (San Antonio, TX)
Assignee: KCI Licensing, Inc.
A61F13/0206A61B5/1477A61B5/14539A61B5/14542A61B5/445A61F13/00059A61F13/00063A61F13/0273A61F13/84C12M45/09A61B5/6833A61F13/0203A61F2013/0094A61F2013/00429A61F2013/00578A61F2013/8473
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,695,228
App. No.
15/591,180
Granted
Jun 30, 2020
Kind
B2
Abstract

A flexible dressing for applying to a tissue site for determining the extent of debridement required to remove non-viable tissue is disclosed. Some embodiments of the dressing may be in the form of a multi-layer drape having an integrated tissue viability indicator system. Some embodiments may also include a system of shapes or a grid pattern printed or embossed on a surface of the drape for providing guidance during an ensuing debridement or amputation procedure.

Claims (55)

1. A dressing for treating a tissue site, comprising:

a drape comprising a first surface and a second surface and a pattern visible on the second surface, wherein the pattern designates a plurality of areas of the drape;

a chemical composition adapted to detect a presence of a tissue viability marker in a plurality of areas of the tissue site corresponding to the plurality of areas of the drape and distinguish viable from non-viable tissue in each area of the plurality of areas of the tissue site corresponding to the plurality of areas of the drape; and

a viability scale adapted to indicate a level of tissue viability associated with the tissue viability marker of each area of the plurality of areas of the tissue site.

2. The dressing of claim 1 , wherein the tissue viability marker is oxygen.

3. The dressing of claim 1 , wherein the tissue viability marker is carbon dioxide.

4. The dressing of claim 1 , wherein the tissue viability marker is pH.

5. The dressing of claim 1 , wherein the chemical composition is further adapted to undergo a color change.

6. The dressing of claim 1 , wherein the chemical composition further comprises an oxygen scavenger.

7. The dressing of claim 1 , further comprising a manifold layer adapted to be positioned adjacent the first surface of the drape.

8. The dressing of claim 7 , wherein the manifold layer comprises a foam.

9. The dressing of claim 1 , further comprising an absorbent layer adapted to be positioned adjacent the first surface of the drape.

10. The dressing of claim 9 , wherein the absorbent layer comprises a superabsorbent material.

11. The dressing of claim 1 , further comprising:

a manifold layer adapted to be positioned proximate the first surface of the drape; and

an absorbent layer adapted to be positioned between the manifold layer and the drape.

12. The dressing of claim 11 , further comprising a perforated layer adapted to be positioned between the manifold layer and the absorbent layer.

13. The dressing of claim 1 , wherein the viability scale comprises a colorimetric scale.

14. The dressing of claim 13 , wherein the colorimetric scale comprises a plurality of colors, wherein each of the plurality of colors corresponds to a different oxygen concentration level.

15. The dressing of claim 1 , wherein the pattern comprises a plurality of concentric shapes.

16. The dressing of claim 1 , wherein the pattern comprises a plurality of concentric circles having an offset of 1 cm.

17. The dressing of claim 1 , wherein the chemical composition comprises a liquid applied to the first surface of the drape.

18. The dressing of claim 1 , wherein the chemical composition comprises a liquid applied to the second surface of the drape.

19. The dressing of claim 18 , further comprising an external sealing layer adapted to be positioned adjacent the chemical composition and the second surface of the drape.

20. The dressing of claim 1 , wherein the chemical composition comprises an assay for an organic enzyme.

21. The dressing of claim 1 , wherein the tissue viability marker is concentration of vascular endothelial growth factor.

22. The dressing of claim 1 , wherein the tissue viability marker is nitric oxide.

23. A dressing for treating a tissue site, comprising:

a drape adapted to be placed proximate the tissue site, comprising:

a tissue interface layer having a first surface and a second surface and comprising an adhesive coating, and

a carrier layer comprising a film coated with an adhesive on a first surface adapted to be positioned in contact with the tissue interface layer and including a pattern visible on a second surface, wherein the pattern designates a plurality of areas of the drape;

a chemical composition adhered to the tissue interface layer and adapted to detect a presence of a tissue viability marker in areas of the tissue site corresponding to the plurality of areas of the drape and distinguish viable from non-viable tissue in the areas of the tissue site corresponding to the plurality of areas of the drape; and

a viability scale applied to the carrier layer and adapted to indicate a level of tissue viability associated with the tissue viability marker.

24. The dressing of claim 23 , wherein the tissue viability marker is oxygen.

25. The dressing of claim 23 , wherein the tissue viability marker is carbon dioxide.

26. The dressing of claim 23 , wherein the tissue viability marker is pH.

27. The dressing of claim 23 , wherein the adhesive coating of the tissue interface layer comprises a silicone gel adhesive having perforations.

28. The dressing of claim 23 , wherein the chemical composition is further adapted to undergo a color change.

29. The dressing of claim 23 , wherein the chemical composition is adhered to the first surface of the tissue interface layer.

30. The dressing of claim 23 , wherein the chemical composition is embedded within the tissue interface layer.

31. The dressing of claim 23 , wherein the carrier layer comprises a polyurethane film.

32. The dressing of claim 23 , wherein the adhesive coated on the carrier layer comprises an acrylic-based adhesive.

33. The dressing of claim 23 , wherein:

the tissue interface layer comprises a plurality of perforations;

the adhesive coated on the carrier layer comprises an acrylic-based adhesive; and

the acrylic-based adhesive is adapted to pass through the plurality of perforations of the tissue interface layer and adhere to portions of the tissue site.

34. A dressing for treating a tissue site, comprising:

a drape adapted to be placed proximate the tissue site, comprising:

a tissue interface layer comprising an adhesive coating, and

a carrier layer comprising a film coated with an adhesive on a first surface adapted to be positioned in contact with the tissue interface layer and including a pattern visible on a second surface and designating a plurality of areas of the drape, and further comprising a plurality of perforations;

a chemical composition adhered to the second surface of the carrier layer and adapted to detect a presence of a tissue viability marker in areas of the tissue site corresponding to the plurality of areas of the drape through the plurality of perforations and distinguish viable from non-viable tissue in the plurality of areas of the drape through the plurality of perforations; and

a viability scale applied to the carrier layer and adapted to indicate a level of tissue viability associated with the tissue viability marker.

35. The dressing of claim 34 , wherein the tissue viability marker is oxygen.

36. The dressing of claim 34 , wherein the tissue viability marker is carbon dioxide.

37. The dressing of claim 34 , wherein the adhesive coating comprises a silicone gel adhesive having perforations.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066436/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0636 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2019
From: LONG, JUSTIN ALEXANDER; GARCIA-OSBORNE, SANDRA; ROBINSON, TIMOTHY MARK; LOCKE, CHRISTOPHER BRIAN; DEKRUIF, DANIEL W.
To: KCI LICENSING, INC.
Reel/Frame 051159/0420 →
Continuity (3)
Provisional Application 62334979 · May 11, 2016
Provisional Application 62334349 · May 10, 2016
Related Publication 20170326004A1 · Nov 16, 2017